Antipsychotics for people with dementia

This publication has 11 references indexed in Scilit:

• A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)
  PLOS Medicine, 2008
• Donepezil for the Treatment of Agitation in Alzheimer's Disease
  New England Journal of Medicine, 2007
• Antipsychotic Drug Use and Mortality in Older Adults with Dementia
  Annals of Internal Medicine, 2007
• The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta‐analysis of 4 placebo‐controlled clinical trials
  International Journal of Geriatric Psychiatry, 2007
• Effectiveness of Nonpharmacological Interventions for the Management of Neuropsychiatric Symptoms in Patients With Dementia
  Archives of internal medicine (1960), 2006
• Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-analysis of Randomized, Placebo-Controlled Trials
  The American Journal of Geriatric Psychiatry, 2006
• Global prevalence of dementia: a Delphi consensus study
  The Lancet, 2005
• Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia
  JAMA, 2005
• Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
  International Journal of Geriatric Psychiatry, 2005
• Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study
  BMJ, 2005